Product Information
DOFETILIDE 250 MCG CAPSULE is a generic product labeled by Mayne Pharma, priced at $0.1886 per EA under NDC 51862002560. Its NADAC has been published 498 times since Aug 17, 2016.
FDA first approved this application on Jun 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Dofetilide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.25 mg/1
Manufacturer
Mayne PharmaNDC
51862002560
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
DOFETILIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207058FDA Approved
6/6/2016
TE Code
AB
On Market Since
6/7/2016
Pharmacological Classes
Price Statistics
The NADAC for DOFETILIDE 250 MCG CAPSULE has been published 498 times since Aug 17, 2016, and over the history we have for it it has declined 97.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1886 per EA |
|---|---|
| All-time high | $6.3432 (Sep 14, 2016) |
| All-time low | $0.1886 (Feb 18, 2026) |
| 52-week high | $0.2178 |
| 52-week low | $0.1886 |
| Median price | $1.2516 |
| Average price | $2.0672 |
| Largest weekly change | +51.6% (Aug 17, 2022) |
| Weeks tracked | 498 |
| Tracking since | Aug 17, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-13.4%
3Y
-71.3%
5Y
-86.4%
All
-97.0%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOFETILIDE 250 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 250 MCG CAPSULE, manufactured by Mayne Pharma, is $0.1886 per EA (NDC 51862002560), effective Feb 25, 2026.
How has the price of DOFETILIDE 250 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOFETILIDE 250 MCG CAPSULE has declined 97.0%. It has been tracked across 498 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for DOFETILIDE 250 MCG CAPSULE?
Since Aug 17, 2016, the NADAC for DOFETILIDE 250 MCG CAPSULE has ranged from a low of $0.1886 (Feb 18, 2026) to a high of $6.3432 (Sep 14, 2016), with a median of $1.2516 per EA.
Are there cheaper alternatives to DOFETILIDE 250 MCG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOFETILIDE 250 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOFETILIDE 250 MCG CAPSULE?
DOFETILIDE 250 MCG CAPSULE (NDC 51862002560) is labeled by Mayne Pharma, and CMS classifies it as a generic product.